You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 1403 Outcomes following first-line immunotherapy with or without chemotherapy stratified by KRAS mutational status – A real world analysis in patients with advanced NSCLC

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Other
1403 Outcomes following first-line immunotherapy with or without chemotherapy stratified by KRAS mutational status – A real world analysis in patients with advanced NSCLC
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to September 2024

AbstractFullPdf
Nov 2022188018
Dec 202269015
Jan 2023106011
Feb 2023106010
Mar 20239407
Apr 20236005
May 202375010
Jun 202376014
Jul 202366011
Aug 20234206
Sep 20232403
Oct 20233909
Nov 20233804
Dec 20234605
Jan 20244005
Feb 20244504
Mar 20246003
Apr 2024401
May 20241504
Jun 20241802
Jul 20242305
Aug 20242807
Sep 20244206
Total13040165